退伍军人菌检测市场报告：2031 年趋势、预测与竞争分析

未来全球退伍军人菌检测市场很可能在医院、诊断实验室和水产养殖市场中看到机会。预计到 2031 年全球退伍军人菌检测市场规模将达到 4.882 亿美元，2025 年至 2031 年的复合年增长率为 7.8%。该市场的主要驱动力是退伍军人菌相关肺炎和疾病发病率的增加以及有关常规水质检测的更严格的规定。

• 根据 Lucintel 的预测，在应用程式类别中，水质检测将在整个预测期内保持较大的份额。
• 就最终用途类别而言，预计海洋产业在预测期内仍将是最大的细分市场。
• 根据地区，北美将在预测期内继续成为最大的地区。

退伍军人菌检测市场的策略性成长机会

退伍军人菌检测市场的策略性成长机会可能来自于能够更广泛地渗透到新市场并改善当前实践的进步和创新。这些机会的全球市场非常广泛，说明在许多领域可能需要技术改进和监管变革才能实现公共卫生目标。

• 先进检测技术的开发：先进的检测技术可以显着提高退伍军人菌检测的敏感度、特异性和效率。投资这些技术将使我们能够提供准确、快速的测试结果，有助于满足对可靠、快速测试日益增长的需求。它还将有助于扩大诊断能力和整体疾病预防/管理。
• 扩展到新兴市场：将退伍军人菌检测服务扩展到新市场为扩大退伍军人菌检测业务提供了巨大的成长前景。重点关注这些地区可以促进市场扩张和改善健康结果，从而增加公众获得优质检测服务的机会并解决新出现的健康问题。这项变革将促进全球经济成长并加强疾病控制倡议。
• 综合环境监测系统：将退伍军人菌检测与环境监测结合，以便于对水质进行全面管理和即时监测。这样做将有助于预防未来的疾病，并对可能发生的退伍军人菌病爆发提供早期预警。这种整合将提高筛检计划的整体有效性和可靠性。
• 强调预防性和主动性检测策略：着重预防性维护措施，例如供水系统维护，可以更容易地在疫情爆发之前识别和解决潜在的集体爆发来源。实际上，这将有助于改善公共卫生结果，同时支持更强大的检测计划。投资预防策略将改善疾病控制，同时减少退伍军人菌病病例的数量。
• 增强的法规遵循解决方案：提供一个解决方案平台，使其能够遵守日益严格的法规，并允许采用具有高品质标准的复杂测试方法。在分析业务其他更广泛变化的背景下，改进的合规机制将解决监管挑战，促进行业成长。这个机会将支持开发更有效、更可靠的筛检程序。

退伍军人菌检测市场的成长机会，例如开发先进技术、进入新市场、与环境监测系统的整合、重视预防性检测以及加强法规遵从性，可能会导致市场大幅扩张。上述策略将有助于更好地管理退伍军人菌病并提高实验室结果的准确性。

退伍军人菌检测市场驱动因素与挑战

退伍军人菌检测市场的成长受到多种市场驱动因素和挑战的影响。技术进步、监管变化和公众意识的提高是主要驱动因素，而高成本、复杂的行业法规和缺乏标准化则构成重大挑战。了解这些因素对于了解该行业和发现成长机会至关重要。

退伍军人菌检测市场驱动因素

1. 技术进步：现代技术的运用大大提高了退伍军人菌检测的准确性。定量聚合酵素链锁反应（PCR）、次世代定序（NGS）和自动化系统等先进程序提高了检测效率并缩短了周转时间。对快速、可靠的筛检结果的需求推动了此类技术的发展。

2. 更严格的监管要求：日益严格的监管要求迫使实验室和设施采用更为复杂的方法来确保合规。遵守最新指南将提高检测结果的品质和可靠性，并实现更好的公共卫生管理。这一趋势导致对先进的退伍军人菌检测解决方案的需求增加。

3. 增强公众健康意识：公众对退伍军人菌和退伍军人菌的认识不断提高，推动了对检测服务的需求。提高对退伍军人菌相关风险的认识将导致人们专注于预防和定期检测，扩大市场并鼓励对先进检测技术的投资。

4. 扩大医疗保健基础设施：医疗保健基础设施的扩大，尤其是在新兴市场的扩大，正在推动退伍军人菌检测计画的开发和实施。对水安全和卫生基础设施的投资将推动对检测解决方案的需求并加强整体疾病控制。此次扩张对于退伍军人菌检测市场的成长起着关键作用。

5. 与环境监测结合：将退伍军人菌检测与环境监测系统结合，可确保全面的水质管理，并可及早发现潜在的疫情。此次整合将提高退伍军人菌检测的有效性，有助于采取更积极主动的疾病预防方法并扩大相关市场。

退伍军人菌检测市场挑战：

1. 初始成本高：先进的测试技术成本高昂，部分实验室和设施难以负担。这种成本障碍可能会限制退伍军人菌检测解决方案的广泛采用，尤其是在预算有限的市场。改善市场进入需要努力降低这些成本障碍，同时不损害测试品质。

2. 复杂的监管要求：退伍军人菌检测的复杂监管要求设置了市场进入障碍并增加了开发成本。测试实验室必须遵守各种法规，以确保产品符合要求的标准。这种复杂性会减缓产业成长、引起用户的抵制并阻碍新解决方案的采用。

3. 标准化程度有限：退伍军人菌检测缺乏标准化，导致不同实验室的结果有差异，进而降低检测结果的可靠性和可信度。建立和实施标准化测试程序将透过提高结果的一致性和增强对退伍军人菌测试解决方案的信心来推动市场成长。

退伍军人菌检测市场受到技术进步、严格的监管要求、不断增强的公众健康意识、不断扩大的医疗保健基础设施以及检测与环境监测系统的整合的推动。然而，高成本、法规复杂以及缺乏标准化等挑战阻碍了市场的成长。克服这些挑战和利用成长动力对于推进测试实践和扩大市场机会至关重要。

目录

第一章执行摘要

第 2动态。

• 简介、背景和分类
• 供应链
• 产业驱动因素与挑战

第 3 章 2019 年至 2031 年的市场趋势与预测分析

• 宏观经济趋势（2019-2024）与预测（2025-2031）
• 全球退伍军人菌检测市场趋势（2019-2024 年）及预测（2025-2031 年）
• 全球退伍军人菌检测市场（依检测类型）
  • 培养方法
  • 尿液抗原检测
  • 直接萤光抗体检测
  • 其他的
• 全球退伍军人菌检测市场（依应用划分）
  • 水质检测
  • 体外诊断测试
  • 其他的
• 全球退伍军人菌检测市场（依最终用途划分）
  • 医院
  • 诊断实验室
  • 渔业
  • 其他的

第 4 章 2019 年至 2031 年各地区的市场趋势与预测分析

• 退伍军人菌检测市场（依地区划分）
• 北美军团退伍军人菌检测市场
• 欧洲退伍军人菌检测市场
• 亚太军团退伍军人菌检测市场
• 世界其他地区退伍军人菌检测市场

第五章 竞争分析

• 产品系列分析
• 营运整合
• 波特五力分析

第六章 成长机会与策略分析

• 成长机会分析
  • 全球退伍军人菌检测市场成长机会（依检测类型）
  • 全球退伍军人菌检测市场成长机会（按应用划分）
  • 全球退伍军人菌检测市场成长机会（依最终用途划分）
  • 全球退伍军人菌检测市场成长机会（按地区划分）
• 全球退伍军人菌检测市场的新趋势
• 战略分析
  • 新产品开发
  • 扩大全球退伍军人菌检测市场的能力
  • 全球退伍军人菌检测市场的合併、收购与合资企业
  • 认证和许可

第七章主要企业简介

• Abbott
• Beckman Coulter
• BD
• Bio-Rad Laboratories
• BIOMERIEUX
• Eiken Chemical
• Hologic
• Pro Lab Diagnostics
• QIAGEN
• F. Hoffmann-La Roche

The future of the global legionella testing market looks promising with opportunities in the hospital, diagnostic laboratory, and water industry markets. The global legionella testing market is expected to reach an estimated $488.2 million by 2031 with a CAGR of 7.8% from 2025 to 2031. The major drivers for this market are the growing occurrences of pneumonia and diseases associated with Legionella bacteria, as well as the rising stricter regulations on routine water testing.

• Lucintel forecasts that, within the application category water testing will remain the larger segment over the forecast period.
• Within the end-use category, the water industry will remain the largest segment over the forecast period.
• In terms of regions, North America will remain the largest region over the forecast period.

Gain valuable insights for your business decisions with our comprehensive 150+ page report.

Emerging Trends in the Legionella Testing Market

Upcoming trends in the legionella testing market denote technological advances, regulatory modifications, and increased attention to public health. These shifts change the way Legionella is detected and managed, drive invention as well as enhance testing precision and speed. Understanding these ideas will be important for stakeholders who want to remain relevant within a constantly changing market.

• Advanced Molecular Diagnostics: Advanced molecular diagnostics have greater sensitivity and specificity in detecting legionella bacteria compared to conventional ways leading to quicker and more accurate results from these tests. These technologies facilitate the detection of small bacterial quantities alongside detailed genomic information that is useful for studying outbreak epidemiology within a public health context.
• Automation and High Throughput Testing: Automation as well as high-throughput systems help streamline testing procedures resulting in raise efficiency while reducing human errors. They are also able to handle large amounts of samples at once hence ideal in hospitals or water treatment plant expansions. The increased throughput capacity coupled with automation increases general turnaround time limits.
• Enhanced Regulatory Requirements: Improved regulatory requirements urge laboratories to employ superior technologies for their diagnostic approaches. Adherence with any updated guidelines assures better quality tests that are reliable and necessary for disease control or prevention purposes. In order to meet these standards and retain compliance labs must invest in new technologies and processes.
• Integration with Environmental Monitoring Systems: Integrating Legionella tests into environmental monitoring systems expands the scope of water quality management. It allows for real-time monitoring and early detection of potential outbreaks of legionella to be proactive in preventing disease transmission. This improves the overall effectiveness of water safety programs and public health measures.
• Increased Focus on Preventative Measures: There is an increased emphasis on prevention strategies for managing Legionella risks, including regular testing and maintenance of water systems. Proactive testing can help identify possible trouble spots before they cause outbreaks, leading to better health outcomes for the public. This trend supports robust testing programs and investment in prevention technologies and practices.

Emerging trends in the industry such as advanced molecular diagnostics, automation, enhanced regulatory requirements, integration with environmental monitoring systems, and increased focus on preventative measures are revolutionizing the market for tests for legionella. Therefore these trends improve the accuracy and efficiency of tests as well as enhance general management within public health when it comes to controlling legionella.

Recent Developments in the Legionella Testing Market

The recent developments in the legionella testing market reflect technological advancements, regulatory changes, and a higher priority given to public health issues. These developments highlight how the industry is responding to emerging demands and challenges that have necessitated improvements in reliability, efficiency in testing, and other factors critical to managing Legionella risks. The following section examines key trends influencing the current state of the industry.

• Adoption of Advanced Molecular Techniques: The Legionella detection process has improved with the adoption of advanced molecular techniques such as polymerase chain reaction (PCR) and Next-Generation Sequencing (NGS). These technologies offer high sensitivity and specificity, enabling rapid identification of Legionella bacteria even in low concentrations. The use of molecular diagnostics is increasing, improving outbreak response and surveillance, and making it easier to track and manage Legionella-related health risks.
• Implementation of Automated Testing Systems: Efficiency in the legionella testing market has been enhanced with the implementation of automated testing systems, which reduce manual errors. These systems allow for high-throughput testing with faster turnaround times, simplifying testing processes. This is especially beneficial for large-scale facilities, such as hospitals and water treatment plants, that need to test many samples at once, allowing for effective management and prevention of outbreaks.
• Strengthening of Regulatory Frameworks: Updates to regulatory frameworks have introduced more stringent guidelines for Legionella testing and management. Regulatory agencies are pushing for advanced testing methods, demanding higher standards in water quality monitoring and laboratory testing. Compliance with these updated regulations makes Legionella detection more accurate and reliable, helping to improve public health outcomes and manage Legionellosis risks more effectively.
• Expansion of Testing Infrastructure: The establishment of new laboratories and the upgrading of existing ones have addressed the growing demand for Legionella testing through the expansion of infrastructure. This trend is particularly prominent in developing markets, where testing capacities are being enhanced to provide better access to quality diagnostic services. The expansion of infrastructure enables effective surveillance and control measures for Legionellosis, supporting better disease prevention efforts.
• Focus on Preventative Strategies: Preventive strategies have become a key focus in managing Legionellosis risks, including periodic sampling, testing, and maintenance of water systems. Proactive testing helps identify potential issues before they lead to outbreaks, supporting early intervention and mitigation efforts. This has led to the development of more robust testing programs for water authorities, with more investments in new technologies and practices that improve water safety and public health.

Recent developments in the legionella testing market, such as the adoption of advanced molecular techniques like NGS and PCR, the implementation of automated systems, and the focus on preventative strategies, are significantly improving testing accuracy and efficiency. These developments also enhance the overall management of Legionella risks, leading to better public health outcomes and driving market growth.

Strategic Growth Opportunities for Legionella Testing Market

Strategic growth opportunities in the legionella testing market may result from advances or innovations that enable wider penetration into new markets and improvement of current practices. The global markets for these opportunities are wide-ranging indicating different sectors with potential for technology improvements or regulatory changes necessary for public health goals.

• Development of Advanced Testing Technologies: Advanced testing technologies can significantly increase sensitivity, specificity, and efficiency in terms of detecting legionella. By investing in these technologies, accurate and prompt results can be produced thus meeting rising demand which are reliable as well as quick. It also supports the expansion of capacity for diagnosis and overall disease prevention/control.
• Penetration into Emerging Markets: Taking legionella testing services into new markets generates substantial growth prospects to expand legionella testing business. By focusing on these areas, market expansion and better health outcomes linked to the improvement of public access to quality testing services and addressing emerging health concerns can be promoted. This change promotes global growth and enhances disease control initiatives.
• Integrated Environmental Monitoring Systems: Integrating Legionella testing with environmental monitoring facilitates comprehensive management of water quality as well as real-time monitoring. By so doing, this path enables prevention of future diseases and early warning about a possible outbreak of legionnaires' disease. Such integration improves the overall efficacy and reliability of the screening programs
• A Greater Emphasis on Preventative and Proactive Testing Strategies: By concentrating on preventive maintenance measures like water system upkeep, it becomes easier to identify and address likely causes of outbreaks before they occur. In effect, this helps improve public health outcomes while supporting stronger test programs. Investing in preventive strategies improves the management of diseases while decreasing the number of cases attributable to legionnaire's disease.
• Augmented Regulatory Compliance Solutions: Providing solution platforms that allow for adherence to ever-tightening rules results in the adoption of sophisticated examination methods at high-quality standards. Improved compliance mechanisms address regulation challenges in order to promote industry growth within this context of other broader changes that concern overall means through which one does analysis work. This opportunity supports more effective development as well as reliable screening programs.

Growth opportunities in the market of legionella testing, such as advanced technology development, new market penetration, integration with environmental monitoring systems, emphasis on preventive testing, and enhanced regulatory compliance may lead to significant expansion of the market. The above strategies can help provide better management for legionnaires disease and improve test result accuracy.

Legionella Testing Market Driver and Challenges

The growth of the legionella testing market is influenced by a combination of drivers and challenges. Technological advancements, changes in regulations, and increased public awareness are key drivers, while high costs, complex industry regulations, and lack of standardization present significant challenges. Understanding these factors is essential to navigating this space and identifying growth opportunities.

Factors Driving the Legionella Testing Market:

1. Technological Advancements: The use of modern techniques has significantly increased the precision of legionella testing. Advanced procedures such as quantitative polymerase chain reaction (PCR), next-generation sequencing (NGS), and automated systems have improved detection efficiency and reduced turnaround times. The development of these technologies is driven by the demand for rapid and reliable screening results, which are essential, especially when cost considerations come into play.

2. Stricter Regulatory Requirements: Increasingly stringent regulatory requirements have forced laboratories and facilities to adopt more sophisticated methods to ensure compliance. Adhering to updated guidelines ensures higher quality and reliability of test results, which supports public health management at larger scales. This trend contributes to the growing demand for advanced Legionella testing solutions.

3. Increased Public Health Awareness: Rising public awareness of Legionella and Legionnaires' disease has driven the demand for testing services. As the recognition of the risks associated with Legionella increases, so does the focus on prevention and periodic testing, thereby expanding the market and encouraging investment in advanced testing technologies.

4. Expansion of Healthcare Infrastructure: The expansion of healthcare infrastructure, particularly in emerging markets, has led to the development and implementation of legionella testing programs. Investments in water safety and public health infrastructure increase the demand for testing solutions and enhance overall disease management. This expansion plays a crucial role in growing the market for Legionella testing.

5. Integration with Environmental Monitoring: The integration of legionella testing with environmental monitoring systems ensures comprehensive water quality management and the ability to detect potential outbreaks before they occur. This integration enhances the effectiveness of Legionella testing and contributes to a more proactive approach to disease prevention, thereby expanding the market.

Challenges in the Legionella Testing Market:

1. High Initial Costs: Advanced testing technologies can be expensive, making them unaffordable for some laboratories and facilities. This cost barrier can limit the penetration of legionella testing solutions, particularly in markets with budget constraints. To improve market access, efforts should be made to reduce these cost barriers without compromising the quality of testing.

2. Complex Regulatory Requirements: The complexity of regulatory requirements for legionella testing can create barriers to market entry and increase development costs. Laboratories must comply with various regulations to ensure their products meet the required standards. This complexity may slow industry growth and create resistance from users, hindering the adoption of new solutions.

3. Limited Standardization: The lack of standardized practices for legionella testing can lead to disparities in results across different laboratories, undermining the reliability and credibility of test outcomes. Establishing and enforcing standardized testing procedures would improve the consistency of results and increase trust in Legionella testing solutions, thus supporting market growth.

The legionella testing market is driven by technological advancements, stricter regulatory requirements, increased public health awareness, the expansion of healthcare infrastructure, and the integration of testing with environmental monitoring systems. However, challenges such as high costs, complex regulations, and lack of standardization hinder market growth. Overcoming these challenges while capitalizing on the growth drivers will be crucial for advancing testing practices and expanding market opportunities.

List of Legionella Testing Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies legionella testing companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the legionella testing companies profiled in this report include-

• Abbott
• Beckman Coulter
• BD
• Bio-Rad Laboratories
• BIOMERIEUX
• Eiken Chemical
• Hologic
• Pro Lab Diagnostics
• QIAGEN
• F. Hoffmann-La Roche

Legionella Testing by Segment

The study includes a forecast for the global legionella testing market by test type, application, end use, and region.

Legionella Testing Market by Test Type [Analysis by Value from 2019 to 2031]:

• Culture Methods
• Urinary Antigen Tests
• Direct Fluorescent Antibody Tests
• Others

Legionella Testing Market by Application [Analysis by Value from 2019 to 2031]:

• Water Testing
• IVD Testing
• Others

Legionella Testing Market by End Use [Analysis by Value from 2019 to 2031]:

• Hospitals
• Diagnostic Laboratories
• Water Industries
• Others

Legionella Testing Market by Region [Analysis by Value from 2019 to 2031]:

• North America
• Europe
• Asia Pacific
• The Rest of the World

Country Wise Outlook for the Legionella Testing Market

The increased awareness of Legionnaires' disease, stringent regulatory requirements, and technological advancements have led to significant developments in the legionella testing market worldwide. These improvements are making testing methods more accurate and efficient, which helps manage and prevent outbreaks more effectively. This overview highlights recent changes in the U.S., China, Germany, India, and Japan markets, reflecting each country's distinct progress and challenges.

• United States: A recent development in the United States is the adoption of advanced molecular techniques, such as polymerase chain reaction (PCR) and next-generation sequencing (NGS), for highly accurate and rapid detection of legionella bacteria. This has led to increased demand for improved testing solutions, especially as the Environmental Protection Agency (EPA) updates guidelines and standards for water testing. Furthermore, there is growing interest in automated test platforms, which may be used in large-scale facilities such as hospitals and water treatment plants, thus improving the accuracy and speed of legionella detection and enhancing public health safety.
• China: The drive to improve healthcare services and meet international standards has been a major factor in recent trends in China's legionella testing market. For example, both private and public sector players have increased their testing capacity by setting up new laboratories or upgrading existing ones. The Chinese government has enacted stricter regulations on water quality monitoring, resulting in the implementation of more sophisticated diagnostic methods. Additionally, there is increased cooperation with other countries to standardize test procedures and improve overall detection capabilities to better manage the pathogen.
• Germany: Advancements in legionella testing in Germany embrace high-throughput screening technologies integrated with enhanced detection approaches. The country has responded to outbreaks by implementing stricter control measures for its population and tightening regulatory standards. New developments include the use of rapid immunoassay technologies and improvements in sample preparation techniques to speed up turnaround times. To ensure a continuous supply of reliable data, Germany has made significant investments in cutting-edge technologies and continues to maintain high standards in public health.
• India: Driven by increasing awareness and regulatory pressure, India has seen growth in its legionella testing market. Recent developments include the introduction of affordable testing solutions and the establishment of more testing facilities, both in urban and rural areas. Public facilities are required by the Indian government to regularly test their water quality, leading to the adoption of advanced testing technologies. Additionally, there is a focus on training and capacity building for laboratory personnel to improve the accuracy and reliability of tests. These advancements have contributed to better management of Legionnaires' disease outbreaks in the country.
• Japan: Japan's approach to the legionella testing market is characterized by technological innovations aimed at preventing disease outbreaks before they occur. Recent innovations include the use of advanced molecular diagnostics and automated assay systems that enhance both speed and accuracy in legionella detection. New regulations have prompted laboratories to invest in more advanced devices, thereby upgrading their diagnostic capacities. By making significant efforts to improve methods for legionella testing, the Japanese government has placed a strong emphasis on research as a key strategy for addressing future challenges, including a better understanding of molecular biology. These developments are expected to improve management practices, reduce the occurrence of Legionella outbreaks, and minimize associated risk factors in Japan's environment.

Features of the Global Legionella Testing Market

Market Size Estimates: Legionella testing market size estimation in terms of value ($M).

Trend and Forecast Analysis: Market trends (2019 to 2024) and forecast (2025 to 2031) by various segments and regions.

Segmentation Analysis: Legionella testing market size by test type, application, end use, and region in terms of value ($M).

Regional Analysis: Legionella testing market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different test types, applications, end uses, and regions for the legionella testing market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the legionella testing market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

If you are looking to expand your business in this or adjacent markets, then contact us. We have done hundreds of strategic consulting projects in market entry, opportunity screening, due diligence, supply chain analysis, M & A, and more.

This report answers following 11 key questions:

• Q.1. What are some of the most promising, high-growth opportunities for the legionella testing market by test type (culture methods, urinary antigen tests, direct fluorescent antibody tests, and others), application (water testing, IVD testing, and others), end use (hospitals, diagnostic laboratories, water industries, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
• Q.2. Which segments will grow at a faster pace and why?
• Q.3. Which region will grow at a faster pace and why?
• Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
• Q.5. What are the business risks and competitive threats in this market?
• Q.6. What are the emerging trends in this market and the reasons behind them?
• Q.7. What are some of the changing demands of customers in the market?
• Q.8. What are the new developments in the market? Which companies are leading these developments?
• Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
• Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
• Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Legionella Testing Market : Market Dynamics

• 2.1: Introduction, Background, and Classifications
• 2.2: Supply Chain
• 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2019 to 2031

• 3.1. Macroeconomic Trends (2019-2024) and Forecast (2025-2031)
• 3.2. Global Legionella Testing Market Trends (2019-2024) and Forecast (2025-2031)
• 3.3: Global Legionella Testing Market by Test Type
  • 3.3.1: Culture Methods
  • 3.3.2: Urinary Antigen Tests
  • 3.3.3: Direct Fluorescent Antibody Tests
  • 3.3.4: Others
• 3.4: Global Legionella Testing Market by Application
  • 3.4.1: Water Testing
  • 3.4.2: IVD Testing
  • 3.4.3: Others
• 3.5: Global Legionella Testing Market by End Use
  • 3.5.1: Hospitals
  • 3.5.2: Diagnostic Laboratories
  • 3.5.3: Water Industries
  • 3.5.4: Others

4. Market Trends and Forecast Analysis by Region from 2019 to 2031

• 4.1: Global Legionella Testing Market by Region
• 4.2: North American Legionella Testing Market
  • 4.2.1: North American Legionella Testing Market by Application: Water Testing, IVD Testing, and Others
  • 4.2.2: North American Legionella Testing Market by End Use: Hospitals, Diagnostic Laboratories, Water Industries, and Others
• 4.3: European Legionella Testing Market
  • 4.3.1: European Legionella Testing Market by Application: Water Testing, IVD Testing, and Others
  • 4.3.2: European Legionella Testing Market by End Use: Hospitals, Diagnostic Laboratories, Water Industries, and Others
• 4.4: APAC Legionella Testing Market
  • 4.4.1: APAC Legionella Testing Market by Application: Water Testing, IVD Testing, and Others
  • 4.4.2: APAC Legionella Testing Market by End Use: Hospitals, Diagnostic Laboratories, Water Industries, and Others
• 4.5: ROW Legionella Testing Market
  • 4.5.1: ROW Legionella Testing Market by Application: Water Testing, IVD Testing, and Others
  • 4.5.2: ROW Legionella Testing Market by End Use: Hospitals, Diagnostic Laboratories, Water Industries, and Others

5. Competitor Analysis

• 5.1: Product Portfolio Analysis
• 5.2: Operational Integration
• 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

• 6.1: Growth Opportunity Analysis
  • 6.1.1: Growth Opportunities for the Global Legionella Testing Market by Test Type
  • 6.1.2: Growth Opportunities for the Global Legionella Testing Market by Application
  • 6.1.3: Growth Opportunities for the Global Legionella Testing Market by End Use
  • 6.1.4: Growth Opportunities for the Global Legionella Testing Market by Region
• 6.2: Emerging Trends in the Global Legionella Testing Market
• 6.3: Strategic Analysis
  • 6.3.1: New Product Development
  • 6.3.2: Capacity Expansion of the Global Legionella Testing Market
  • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Legionella Testing Market
  • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

• 7.1: Abbott
• 7.2: Beckman Coulter
• 7.3: BD
• 7.4: Bio-Rad Laboratories
• 7.5: BIOMERIEUX
• 7.6: Eiken Chemical
• 7.7: Hologic
• 7.8: Pro Lab Diagnostics
• 7.9: QIAGEN
• 7.10: F. Hoffmann-La Roche